Company news
Clever Culture Systems Limited (ASX:CC5) news
Clever Culture Systems Limited news releases on 6ix. Latest, Oct 27, 2017: Autobio $2M Placement in LBT & MicroStreak IP Transfer
Press releases — page 3
Autobio $2M Placement in LBT & MicroStreak IP Transfer
October 27, 2017
LBT Receives $4.2 Million in R&D Incentives
October 9, 2017
ST Vincents Hospital Commences APAS Automated Evaluation
September 26, 2017
LBTs WoundVue Prototype to be used at CALHN
August 8, 2017
CE Mark Self Certification Finalised for APAS
June 22, 2017
ST VINCENTS HOSPITAL MELBOURNE TO BE FIRST APAS TRIAL SITE
June 20, 2017
LBT Appointed Distributor for Australia and New Zealand
June 14, 2017
Share Purchase Plan Offer
May 23, 2017
APAS INCLUDED ON THE AUSTRALIAN TGA REGISTER
March 27, 2017
Completion of Placement
December 1, 2016
LBT Innovations Granted New Patent for United States
November 10, 2016
US FDA GRANTS APPROVAL FOR APAS
October 9, 2016
LBT granted patent in Japan for core APAS technology
May 19, 2016
Cochlear Executive Brent Barnes Appointed CEO of LBT
May 9, 2016
LBT Receives Notice of Allowance for Third Patent
April 6, 2016
LBT Begins Clinical Trials of APAS Technology
March 30, 2016
LBT Innovations Completes U.S. Regulatory Submission
February 11, 2016
LBT Concludes APAS Clinical Trial Program
February 10, 2016